Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Efficacy and safety of PCSK9 inhibitors in real life
Antón González-Guerrero; Eugenia Navarrete-Rouco; David Benaiges; Eva Giralt-Steinhauer; Lidia Marcos; Anna Oliveras; Lluis Recasens; Juan Pedro-Botet;
Clin Investig Arterioscler. 2025;37:
Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study
Agustín Blanco Echevarría; Juan De Dios García Díaz; Assumpta Caixas; Núria Plana Gil; Miguel Ángel Rico Corral; Ian Bridges; Nafeesa Dhalwani; Sònia Gatell Menchen; Kausik K. Ray;
Clin Investig Arterioscler. 2023;35:263-71
Multizonal observational study conducted by clinical practitioners on Repatha® use in patients with hyperlipidemia (ZERBINI): Colombian results
Heidy M. Roncancio; Julián R. Lugo-Peña; Ángel A. García; Janeth Leal; Carlos A. Hoyos; Johnny A. Beltrán; César L. Cruz; Carol Paez-Cano; Mariana Pineda-Posada; Eduardo Contreras;
Clin Investig Arterioscler. 2024;36:22-32